Health Care & Life Sciences » Pharmaceuticals | Nissui Pharmaceutical Co. Ltd.

Nissui Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
3,644
3,721
2,916
2,584
1,691
1,382
Depreciation, Depletion & Amortization
351
323
341
405
388
380
Other Funds
1,661
3,086
1,779
1,319
704
422
Funds from Operations
2,333
958
1,477
1,670
1,372
1,340
Changes in Working Capital
216
433
84
408
443
81
Net Operating Cash Flow
2,117
1,391
1,562
1,263
929
1,421
Capital Expenditures
575
198
517
470
524
Sale of Fixed Assets & Businesses
-
-
1
2,036
873
Purchase/Sale of Investments
2,857
833
2,214
9,996
18
Net Investing Cash Flow
1,331
1,070
2,724
11,527
298
Cash Dividends Paid - Total
762
850
917
892
891
Issuance/Reduction of Debt, Net
3
2
134
36
37
Net Financing Cash Flow
765
853
784
929
929
Net Change in Cash
20
1,608
1,945
11,862
298
Free Cash Flow
1,543
1,203
1,122
807
419
Other Sources
2,100
2,100
7
-
-
Change in Capital Stock
-
1
1
-
-
Other Uses
-
-
-
35
69

About Nissui Pharmaceutical Co.

View Profile
Address
Nissuiseiyaku Building
Tokyo Tokyo 110
Japan
Employees -
Website http://www.nissui-pharm.co.jp
Updated 07/08/2019
Nissui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of culture media and diagnostics for medical institutions, research organizations, and food industries. Its operations are carried out through the following segments: Clinical Diagnostics and Pharmaceuticals. The Clinical Diagnostics segment provides reagents and instruments for microbiological and immunological tests, and also quality control materials for human diagnostic use, food sanitation use and biological research in both the public and private organizations.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.